Falls Risk Questionnaire in Older Adults With Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02204137|
Recruitment Status : Completed
First Posted : July 30, 2014
Last Update Posted : May 1, 2017
|Condition or disease||Intervention/treatment|
|Cancer Geriatric Assessment||Other: Falls Risk Questionnaire Other: Cancer and Aging Research Group Geriatric Assessment Other: Falls Efficacy Scale-International (FES-1) Other: Health Related Quality of Life using the Functional Assessment of Cancer Therapy - Gynecologic Oncology Group Neurotoxicity Scale (FACT GOG/NTX)|
|Study Type :||Observational|
|Actual Enrollment :||21 participants|
|Official Title:||Pilot Study of the Falls Risk Questionnaire in Older Adults With Cancer|
|Study Start Date :||August 2014|
|Actual Primary Completion Date :||November 2014|
|Actual Study Completion Date :||November 2014|
Completion of Questionnaires
Participants will complete an assessment consisting of the Falls Risk Questionnaire, a primarily self-administered geriatric assessment (GA) developed by the Cancer and Aging Research Group, a quality of life scale (FACT GOG/NTX) and the Falls Efficacy Scale-International.
Each questionnaire contains approximately 150 questions and will take between 30 minutes and one hour to complete.
Other: Falls Risk Questionnaire
Other: Cancer and Aging Research Group Geriatric Assessment
Other: Falls Efficacy Scale-International (FES-1)
Other: Health Related Quality of Life using the Functional Assessment of Cancer Therapy - Gynecologic Oncology Group Neurotoxicity Scale (FACT GOG/NTX)
- Percent completion of the Fall Risk Questionnaire (FRQ) and the Cancer and Aging Research Group Geriatric Assessment (CARG GA) of enrolled patients [ Time Frame: Day 1 ]The percent of patients who complete the assessment will be calculated. Successful completion will be defined as the completion of all items on the questionnaires. If more than 85% of subjects are able to complete the FRQ and CARG GA, the assessment will be deemed feasible.
- Time to completion of FRQ and CARG GA of enrolled patients [ Time Frame: Day 1 ]
- Satisfaction with the questionnaires [ Time Frame: Day 1 ]We will calculate the frequency of participant feedback that 1) certain questions that were difficult to understand 2) the questionnaire was too short or too long 3) questions were upsetting or 4) the questionnaire left out important questions to ask. Open-ended follow-up questions in which the participants will be given the opportunity to write out their responses will be examined qualitatively for recurring themes of particular questions that were unsatisfactory
- Psychological consequences of falling [ Time Frame: Day 1 ]Uses the Falls Efficacy Scale-International (FES-I) and Health Related Quality of Life (HRQOL) using the Functional Assessment of Cancer Therapy - Gynecologic Oncology Group Neurotoxicity Scale (FACT GOG/NTX)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02204137
|United States, Missouri|
|Washington University School of Medicine|
|Saint Louis, Missouri, United States, 63110|
|Principal Investigator:||Tanya Wildes, M.D., M.S.C.I.||Washington University School of Medicine|